Infectious diseases are among the most challenging issues facing health care delivery systems around the world today. The World Health Organisation estimates that more than 17 million people die of an infectious disease each year, with many of these acquired in hospitals. This Kalorama Information report, The World Market for Infectious Disease Diagnostic Tests, takes a comprehensive look at the markets for companies of testing products that can combat infectious disease threats.
One of the Most Dynamic Areas of the IVD Market, Comprehensively Covered
The art of microorganism identification and therapy decisions is becoming increasingly more important and more complex. This provides both challenges and opportunities for infectious disease testing. The world is getting smaller and smaller - people and products are moving over country boundaries as never before. Immigrants and visitors to countries bring with them different species of microorganisms that may require identification. Therefore highly sophisticated and versatile methodologies are required to respond for the need to identify a larger and more diversified list of pathogens. The report provides a review of trends and technological advancements in infectious disease testing in the next 5 years.
Market Size and Sales Forecasts to 2017 by Type of Test
Sales and forecasts of infectious disease reagents are made through to 2017. Emerging products and markets are described; key players and strategies discussed and competitive trends are analyzed. Specific market details are provided for the following:
Market analysis in this report covers world markets for infectious disease tests, however the reader will find a bias toward the developed areas of the globe -- North America, Japan and Western Europe. The BRIC set of countries (Brazil, Russia, India and China) have drawn a lot of attention in the economic media in the past 2 -3 years. Thus there is more discussion of the mix of economics and diagnostics that may evolve in these countries. Nevertheless, infectious diseases are a growing global problem and where possible the report covers IVD products related to the globalization of diseases.
All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Data for the in vitro diagnostic market are presented in U.S. dollar market size for categories of tests, and for specific analytes where possible. The dollar value of a market segment is directly proportional to the number of tests performed, because the cost of the instrumentation is generally buried in the per test price.
The Threat of Emerging Infectious Disease
Globalization has made the world a smaller place in a very short time. There are numerous reports of the spread of imported diseases such a lyme, chagas and malaria to regions where they were not usually present. Global travel and trade, along with climate change, are expanding the habitats of the mosquitoes that carry many of the vector-borne infectious disease far and wide.
Thus not only is it imperative to have rapid and efficient tests for countries in the developing world, healthcare providers in developed countries can also benefit. The situation in developed countries is probably less urgent for the tropical diseases, but it is equally important to have better rapid tests for hepatitis, HIV, tuberculosis and sexually transmissible diseases worldwide. The following diseases are covered in the report in detail.
For each of these diseases, the report provides statistics, and an estimate of the opportunity for IVD companies.
The report discusses tests and technologies that are currently available and those that are expected to take their place. Generally, current products and technologies establish the standard of care and its value to payers. Many of the assays and techniques presented in the report are expected to replace the standard of care in 2012, but with healthcare systems’ emphasis on cost/benefit analysis for new technologies adoption, the market value and thus penetration capabilities of newer approaches may be limited.
Exhaustive Company Profiling
The information contained in this report has been assembled from primary and secondary data. Secondary date was collected from peer review journals and industry generated press releases. Primary research was conducted via telephone conversation with selected diagnostic marketers of in vitro diagnostics to assess the current market and trends in laboratory medicine.
Related Reports:The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 10th Edition
Aug 22, 2016 - KLI15067157 - $6,995.00
What You May Have Missed at AACC 2016: The World's Largest Laboratory and IVD Supplier Convention
Aug 9, 2016 - KLI15081270 - $0.00
The World Market for Point of Care (POC) Diagnostics and The Market for Molecular POC Diagnostics
Jul 28, 2016 - KLI15068620 - $7,500.00
The World Market for Ultrasound Systems (Traditional, Portable, Handheld, Therapeutic Category Markets)
Jul 7, 2016 - KLI15049235 - $4,200.00
United States Market for In Vitro Diagnostic Tests
Jun 27, 2016 - KLI15035998 - $4,200.00
The World Market for Companion Diagnostic Tests
Jun 7, 2016 - KLI15021881 - $4,200.00
The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)
Jun 6, 2016 - KLI15021669 - $4,200.00
Surgical Procedure Volumes: Global Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, France, Italy, Mexico, Australia, Canada)
May 20, 2016 - KLI15006734 - $4,200.00
The Global Market for Medical Devices, 7th Edition
May 13, 2016 - KLI15002686 - $1,500.00
Blood Testing Market in China (Typing, Immunoassay, NAT Testing)
Apr 20, 2016 - KLI5975604 - $2,500.00
Questions?Contact a research specialist >
Live Chat Software
Most Popular ResearchRetail Clinics 2015: Growth of Stores, Consumer Opinion, Leading Competitors, Sales of Products to Clinics (Diagnostic Tests, Pharmaceuticals, Vaccines), Clinic Sales Forecasts and Trends World Market for Prescription Dermatological Drugs, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments) Offshoring Contract Research Activities: White Paper Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others) Out-of-Pocket Healthcare Expenditures in the United States The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment